06- Physician-Writer Series: David Fajgenbaum, MD (Castleman Disease Collaborative Network)

Episode 9 September 08, 2021 00:42:19
06- Physician-Writer Series: David Fajgenbaum, MD (Castleman Disease Collaborative Network)
Physicians Off The Beaten Path
06- Physician-Writer Series: David Fajgenbaum, MD (Castleman Disease Collaborative Network)

Sep 08 2021 | 00:42:19

/

Hosted By

Alexey Youssef Shad Faraz

Show Notes

What is it like to navigate the healthcare system both as a healthcare professional and as a patient? What is the state of research for rare diseases right now? Is an MBA important for docs to consider? In this episode, we answer all these questions and more with our guest David Fajgenbaum, MD.

David is an assistant professor of medicine in Translational Medicine & Human Genetics at the University of Pennsylvania. He's also the founding director of the center for Cytokine Storm Treatment & Laboratory (CSTL). He is the co-founder/president of the Castleman Disease Collaborative Network (CDCN). David is the national bestselling author of 'Chasing My Cure: A Doctor's Race to Turn Hope Into Action'. The book describes his harrowing and hopeful journey to spearhead the search for a cure for his disease.

If you've found our podcast helpful, buy us a coffee

Other Episodes

Episode 23

May 04, 2022 00:44:18
Episode Cover

23- Physician-Entrepreneur Series: Iman Abuzeid (Incredible Health)

Is there a specific path to entrepreneurship MDs need to follow? What does the demand and supply dynamics in the nursing market look like?...

Listen

Episode 4

July 28, 2021 00:44:24
Episode Cover

04- Physician-Consultant Series: Dr. Felix Matthews (Deloitte)

What exactly is the role of a physician-consultant? What is the value of working at the intersection of disciplines? And what exciting technology trends...

Listen

Episode 10

November 03, 2021 00:42:17
Episode Cover

10- Physician-Executive Series: Sachin H. Jain, MD (SCAN Group and Health Plan)

What is the mission of big corporations in the healthcare business? How is AI going to impact the drug development continuum in the next...

Listen